One survey puts the toll of lost productivity and caring for diabetes patients at $218 billion annually in the U.S. alone.
Yet for investors, the fast-growing diabetes industry suggests something else: THE PFIZER OPPORTUNITY.
_____________________________________________________________________________________
adChange™